Tirzepatide, a recently approved medication, is generating excitement as a potential treatment for individuals facing type 2 diabetes . Unlike common diabetes therapies, it functions through a dual mechanism, targeting both the GLP-1 receptor and the GIP hormone receptors. Clinical data have reve